126 related articles for article (PubMed ID: 2418497)
1. A prospective comparative study on serum acid phosphatases in the diagnostics of prostatic cancer.
Seppänen J; Setälä E; Tunturi T
Scand J Urol Nephrol; 1985; 19(4):247-51. PubMed ID: 2418497
[TBL] [Abstract][Full Text] [Related]
2. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
[TBL] [Abstract][Full Text] [Related]
3. Elevation of serum prostatic acid phosphatase levels after prostatic massage.
Wadström J; Huber P; Rutishauser G
Urology; 1984 Dec; 24(6):550-1. PubMed ID: 6209846
[TBL] [Abstract][Full Text] [Related]
4. Lack of value of radioimmunoassay for prostatic acid phosphatase as a screening test for prostatic cancer in patients with obstructive prostatic hyperplasia.
Fleischmann J; Catalona WJ; Fair WR; Heston WD; Menon M
J Urol; 1983 Feb; 129(2):312-4. PubMed ID: 6187945
[TBL] [Abstract][Full Text] [Related]
5. [Prostatic acid phosphatase by enzymeimmunoassay].
Masukagami T; Ando K; Shimazaki J
Hinyokika Kiyo; 1984 Nov; 30(11):1691-5. PubMed ID: 6084950
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia.
Bogdanowicz JF; Bentvelsen FM; Oosterom R; Schroeder FH
Scand J Urol Nephrol Suppl; 1991; 138():97-103. PubMed ID: 1723815
[TBL] [Abstract][Full Text] [Related]
7. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
Canal P; Soula G
Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay of serum prostatic acid phosphatase after prostatic massage.
Pearson JC; Dombrovskis S; Dreyer J; Williams RD
Urology; 1983 Jan; 21(1):37-41. PubMed ID: 6186064
[TBL] [Abstract][Full Text] [Related]
9. Prostatic acid phosphatase by radioimmunoassay. Sensitivity compared with enzymatic assay.
Lindholm GR; Stirton S; Liedtke RJ; Batjer JD
JAMA; 1980 Nov; 244(18):2071-3. PubMed ID: 6159488
[TBL] [Abstract][Full Text] [Related]
10. Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase.
Bauer HW; Schmeller NT
Urology; 1984 Mar; 23(3):247-51. PubMed ID: 6199879
[TBL] [Abstract][Full Text] [Related]
11. Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
Vihko P; Kontturi M; Lukkarinen O; Vihko R
J Urol; 1982 Oct; 128(4):739-41. PubMed ID: 6183458
[TBL] [Abstract][Full Text] [Related]
12. Comparison of enzyme-linked immunosorbent assay and radioimmunoassay for prostate-specific acid phosphatase in prostatic disease.
Griffiths J; Rippe DF; Panfili PR
Clin Chem; 1982 Jan; 28(1):183-6. PubMed ID: 7055908
[TBL] [Abstract][Full Text] [Related]
13. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.
Foti AG; Cooper JF; Herschman H; Malvaez RR
N Engl J Med; 1977 Dec; 297(25):1357-61. PubMed ID: 73133
[TBL] [Abstract][Full Text] [Related]
14. Comparison of radioimmunoassay and immunoradiometric assay for serum prostatic acid phosphatase.
Sturgeon CM; Hussey AJ; Beynon L; Ritchie A; Chisholm GD; Micklem L; James K; Seth J
Clin Chim Acta; 1986 Nov; 161(1):47-57. PubMed ID: 2434268
[TBL] [Abstract][Full Text] [Related]
15. [Serum acid phosphatase determined by the radioimmunochemical method (P.A.P.-RIA): its diagnostic value in prostatic cancer].
Marczyńska A; Kulpa J; Adamczyk B; Leńko J
Przegl Lek; 1982 Sep; 39(8):573-6. PubMed ID: 6182582
[No Abstract] [Full Text] [Related]
16. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
Watanabe M; Kitamura Y; Komatsubara S; Sakata Y
Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
[TBL] [Abstract][Full Text] [Related]
17. [Prostatic acid phosphatase (PAP), gamma-seminoprotein (gamma-Sm) and prostate specific antigen (PA) in prostatic cancer].
Akimoto S; Akakura K; Shimazaki J
Hinyokika Kiyo; 1988 Aug; 34(8):1389-96. PubMed ID: 2461644
[TBL] [Abstract][Full Text] [Related]
18. Prostatic cancer, acid phosphatase, creatine kinase-BB and race: a prospective study.
Fair WR; Heston WD; Kadmon D; Crane DB; Catalona WJ; Ladenson JH; McDonald JM; Noll BW; Harvey G
J Urol; 1982 Oct; 128(4):735-8. PubMed ID: 6183457
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serum arginase activity in benign prostatic hypertrophy and prostatic cancer.
Elgün S; Keskineğe A; Yilmaz E; Baltaci S; Bedük Y
Int Urol Nephrol; 1999; 31(1):95-9. PubMed ID: 10408309
[TBL] [Abstract][Full Text] [Related]
20. Serum acid phosphatase in patients with localised prostatic cancer, benign prostatic hyperplasia or normal prostates.
Salo JO; Rannikko S; Haapiainen R
Br J Urol; 1990 Aug; 66(2):188-92. PubMed ID: 1697205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]